Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cell Death and Differentiation

• Publication date

  2008-01-25

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/sj.cdd.4402309PMID 18219319
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Mdm2 RING domain C‐terminus is required for supramolecular assembly and ubiquitin ligase activity

  2007cited by this paper
• MDMX: from bench to bedside

  2007influential reference
• Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation.

  2007influential reference
• RING domain-mediated interaction is a requirement for MDM2's E3 ligase activity.

  2007cited by this paper
• An essential function of the extreme C‐terminus of MDM2 can be provided by MDMX

  2007influential reference
• Hetero-oligomerization with MdmX Rescues the Ubiquitin/Nedd8 Ligase Activity of RING Finger Mutants of Mdm2*

  2007cited by this paper
• p53 in health and disease

  2007cited by this paper
• Automated structure solution with autoSHARP.

  2007cited by this paper
• Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53.

  2006influential reference
• p53 ubiquitination: Mdm2 and beyond.

  2006cited by this paper
• Structure and E3‐ligase activity of the Ring–Ring complex of Polycomb proteins Bmi1 and Ring1b

  2006influential reference
• The Prp19 U-box crystal structure suggests a common dimeric architecture for a class of oligomeric E3 ubiquitin ligases.

  2006cited by this paper
• Regulation of MDMX nuclear import and degradation by Chk2 and 14‐3‐3

  2006cited by this paper
• Structure of a Bmi-1-Ring1B Polycomb Group Ubiquitin Ligase Complex*

  2006cited by this paper
• Chaperoned ubiquitylation--crystal structures of the CHIP U box E3 ubiquitin ligase and a CHIP-Ubc13-Uev1a complex.

  2005cited by this paper
• Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells.

  2005influential reference
• Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundance.

  2005cited by this paper
• DNA Damage-Induced Phosphorylation of MdmX at Serine 367 Activates p53 by Targeting MdmX for Mdm2-Dependent Degradation

  2005cited by this paper
• Mechanistic insight into the allosteric activation of a ubiquitin-conjugating enzyme by RING-type ubiquitin ligases.

  2005cited by this paper
• Accelerated MDM2 auto‐degradation induced by DNA‐damage kinases is required for p53 activation

  2004influential reference
• In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

  2004influential reference
• Amplification of Mdmx (or Mdm4) Directly Contributes to Tumor Formation by Inhibiting p53 Tumor Suppressor Activity

  2004cited by this paper
• Regulating the p53 system through ubiquitination

  2004cited by this paper
• Regulation of p53 by Mdm2: fate is in the numbers.

  2004cited by this paper
• Inhibition of p53 degradation by Mdm2 acetylation

  2004cited by this paper
• Coot: model-building tools for molecular graphics.

  2004cited by this paper
• Hdmx Protein Stability Is Regulated by the Ubiquitin Ligase Activity of Mdm2*

  2003influential reference
• HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53

  2003cited by this paper
• Mutual Dependence of MDM2 and MDMX in Their Functional Inactivation of p53*

  2002cited by this paper
• Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex

  2002cited by this paper
• p53 contains large unstructured regions in its native state.

  2002cited by this paper
• Structure of a BRCA1–BARD1 heterodimeric RING–RING complex

  2001cited by this paper
• Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms

  2001cited by this paper
• The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation*

  2001cited by this paper
• Multiple C-Terminal Lysine Residues Target p53 for Ubiquitin-Proteasome-Mediated Degradation

  2000cited by this paper
• Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53*

  2000cited by this paper
• Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases.

  2000influential reference
• MDM2 interacts with MDMX through their RING finger domains

  1999cited by this paper
• Stabilization of the MDM2 Oncoprotein by Interaction with the Structurally Related MDMX Protein*

  1999cited by this paper
• Automated protein model building combined with iterative structure refinement

  1999cited by this paper
• The CCP4 suite: programs for protein crystallography.

  1994cited by this paper

• The Structure, Pathogenesis, and Inhibition of the p53-MDM2 Pathway.

  2026cites this paper
• Roles of E3 ubiquitin ligases and deubiquitinating enzymes in renal cell carcinoma

  2026cites this paper
• Reduced structural rigidity of MDMX protein enhances binding to TP53 mRNA

  2025cites this paper
• Structure and function of MDM2 and MDM4 in health and disease

  2025influential citation
• Exploring the heterodimer MDM2/MDM4 interaction region uncovers high-affinity peptides for therapeutic p53-reactivation

  2025cites this paper
• Development of MDM2‐Targeting PROTAC for Advancing Bone Regeneration

  2025cites this paper
• Targeting p53 activation: Recent therapeutic advances in cancer and diabetic macular edema.

  2025cites this paper
• Reduction of lymphotoxin beta receptor induces cellular senescence via the MDMX-p53 pathway

  2025cites this paper
• Unraveling the Guardian: p53’s Multifaceted Role in the DNA Damage Response and Tumor Treatment Strategies

  2024cites this paper
• An overview of PROTACs targeting MDM2 as a novel approach for cancer therapy.

  2024cites this paper
• Rational design, synthesis, and biophysical characterization of a peptidic MDM2-MDM4 interaction inhibitor.

  2024cites this paper
• Hdm2 disrupts HdmX-mediated nuclear export of p53 by sequestering it in nucleus.

  2024cites this paper
• Development and Nanoparticle-Mediated Delivery of Novel MDM2/MDM4 Heterodimer Peptide Inhibitors to Enhance 5-Fluorouracil Nucleolar Stress in Colorectal Cancer Cells.

  2024cites this paper
• Oligomerization mediated by the D2 domain of DTX3L is critical for DTX3L‐PARP9 reading function of mono‐ADP‐ribosylated androgen receptor

  2024cites this paper
• Unraveling the role of ubiquitin-conjugating enzyme 5 (UBC5) in disease pathogenesis: A comprehensive review.

  2024cites this paper
• Cellular, Structural Basis, and Recent Progress for Targeting Murine Double Minute X (MDMX) in Tumors.

  2024cites this paper
• Targeting G-rich sequence to regulate the transcription of murine double minute (MDM) genes in triple-negative breast cancers.

  2024cites this paper
• MDMX in Cancer: A Partner of p53 and a p53-Independent Effector

  2024cites this paper
• Zooming into the structure-function of RING finger proteins for anti-cancer therapeutic applications.

  2023cites this paper
• Discovery of JN122, a Spiroindoline-Containing Molecule that Inhibits MDM2/p53 Protein-Protein Interaction and Exerts Robust In Vivo Antitumor Efficacy.

  2023cites this paper
• Targeting p53 pathways: mechanisms, structures and advances in therapy

  2023cites this paper
• B-box1 Domain of MID1 Interacts with the Ube2D1 E2 Enzyme Differently Than RING E3 Ligases.

  2023cites this paper
• FAM193A is a positive regulator of p53 activity

  2023cites this paper
• The roles of E3 ubiquitin ligases in cancer progression and targeted therapy

  2023cites this paper
• Oligomerisation mediated by the D2 domain of DTX3L is critical for DTX3L-PARP9 reading function of mono-ADP-ribosylated androgen receptor

  2023cites this paper
• Current and future perspectives on the regulation and functions of miR-545 in cancer development

  2023cites this paper
• Genome-wide identification and spatiotemporal expression profiling of zinc finger SWIM domain-containing protein family genes

  2023cites this paper
• P53 protein and the diseases in central nervous system

  2023cites this paper
• Advances in the Anti-Tumor Activity of Biflavonoids in Selaginella

  2023cites this paper
• Synthesis, Docking Study, and Biological Evaluation of 2‐Phenylchroman‐4‐one Derivatives as Murine Double Minute 2 (MDM2) Inhibitors

  2023cites this paper
• Structure-Based Discovery of MDM2/4 Dual Inhibitors that Exert Antitumor Activities against MDM4-Overexpressing Cancer Cells.

  2022cites this paper
• 1H, 15N and 13C backbone resonance assignments of the acidic domain of the human MDM2 protein

  2022cites this paper
• The MDMX acidic domain competes with the p53 transactivation domain for MDM2 N-terminal domain binding.

  2022cites this paper
• p53-mediated metabolic response to low doses of ionizing radiation

  2022cites this paper
• 1H, 15N and 13C backbone resonance assignments of the acidic domain of the human MDMX protein

  2022cites this paper
• Review of the Structural Basis of Human E2 Conjugating Enzymes in Complexed with RING E3 Ligases

  2022cites this paper
• Reconstitution of the DTX3L-PARP9 complex reveals determinants for high affinity heterodimerization and multimeric assembly.

  2022cites this paper
• Hinokiflavone Inhibits MDM2 Activity by Targeting the MDM2-MDMX RING Domain

  2022cites this paper
• Activating the p53 anti-cancer pathway by targeting the MDM2/MDMX dimer interface with short peptide segments: a computational peptide design experiment

  2022cites this paper
• Structure of the nutrient-sensing hub GATOR2

  2022cites this paper
• Dual Targeting of MDM4 and FTH1 by MMRi71 for Induced Protein Degradation and p53-Independent Apoptosis in Leukemia Cells

  2022cites this paper
• MDM2 E3 ligase activity is essential for p53 regulation and cell cycle integrity

  2022cites this paper
• Critical role of cysteine-266 of SIE3 in regulating the ubiquitination and degradation of SIP1 transcription factor in Lotus japonicus

  2021cites this paper
• Arsenic co-carcinogenesis: inhibition of DNA repair and interaction with zinc finger proteins.

  2021cites this paper
• Reconstitution of the DTX3L-PARP9 complex reveals determinants for high affinity heterodimer formation and enzymatic function

  2021cites this paper
• Studying Homo-oligomerization and Hetero-oligomerization of MDMX and MDM2 Proteins in Single Living Cells by Using In Situ Fluorescence Correlation Spectroscopy.

  2021cites this paper
• Recent Progress and Clinical Development of Inhibitors that Block MDM4/p53 Protein-Protein Interactions.

  2021cites this paper
• GID E3 ligase supramolecular chelate assembly configures multipronged ubiquitin targeting of an oligomeric metabolic enzyme

  2021cites this paper
• The roles and regulation of MDM2 and MDMX: it is not just about p53

  2021influential citation
• MDMX is essential for the regulation of p53 protein levels in the absence of a functional MDM2 C-terminal tail

  2021cites this paper
• Ubiquitination Enzymes

  2021cites this paper
• Killing by Degradation: Regulation of Apoptosis by the Ubiquitin-Proteasome-System

  2021cites this paper
• New insight into the role of MDMX in MDM2-mediated p53 degradation and anti-cancer drug development

  2021cites this paper
• Identification of a Catalytic Active but Non-Aggregating MDM2 RING Domain Variant

  2021cites this paper
• p53 Activation Effect in the Balance of T Regulatory and Effector Cell Subsets in Patients With Thyroid Cancer and Autoimmunity

  2021cites this paper
• Understanding the interaction of 14‐3‐3 proteins with hDMX and hDM2: a structural and biophysical study

  2021cites this paper
• UBC13 is an RNF213‐associated E2 ubiquitin‐conjugating enzyme, and Lysine 63‐linked ubiquitination by the RNF213‐UBC13 axis is responsible for angiogenic activity

  2021cites this paper
• p53-dependent and -independent mechanisms of p53-targeting small molecules

  2020cites this paper
• The MDM2/MDMX/p53 axis in the adaptive stress response

  2020cites this paper
• Arabidopsis RING-type E3 ubiquitin ligase XBAT35.2 promotes proteasome-dependent degradation of ACD11 to attenuate abiotic stress tolerance.

  2020cites this paper
• NEDD8 and ubiquitin ligation by cullin-RING E3 ligases.

  2020cites this paper
• Structural basis for DNA damage-induced phosphoregulation of MDM2 RING domain

  2020cites this paper
• Germline mutation of MDM4, a major p53 regulator, in a familial syndrome of defective telomere maintenance

  2020cites this paper
• Targeting the Ubiquitin System in Glioblastoma

  2020cites this paper
• Anticancer strategies by upregulating p53 through inhibition of its ubiquitination by MDM2

  2020cites this paper
• The Potential of Proteolytic Chimeras as Pharmacological Tools and Therapeutic Agents

  2020cites this paper
• RBM10, a New Regulator of p53

  2020cites this paper
• Interaction mapping of endoplasmic reticulum ubiquitin ligases identifies modulators of innate immune signalling

  2020cites this paper
• How to Inactivate Human Ubiquitin E3 Ligases by Mutation

  2020cites this paper
• Mdm2 and MdmX RING Domains Play Distinct Roles in the Regulation of p53 Responses: A Comparative Study of Mdm2 and MdmX RING Domains in U2OS Cells

  2020cites this paper
• Effect of p53 activation through targeting MDM2/MDM4 heterodimer on T regulatory and effector cells in the peripheral blood of Type 1 diabetes patients

  2020cites this paper
• Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives

  2020cites this paper
• The expression of zinc finger 804a (ZNF804a) and cyclin-dependent kinase 1 (CDK1) genes is related to the pathogenesis of rheumatoid arthritis

  2020cites this paper
• Mdm2 enhances ligase activity of parkin and facilitates mitophagy

  2020cites this paper
• Competitive ubiquitination activates the tumor suppressor p53

  2019cites this paper
• Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells.

  2019cites this paper
• Promising Terpenes as Natural Antagonists of Cancer: An In-Silico Approach

  2019cites this paper
• A Single Conserved Amino Acid Residue as a Critical Context-Specific Determinant of the Differential Ability of Mdm2 and MdmX RING Domains to Dimerize

  2019cites this paper
• p53 promotes its own polyubiquitination by enhancing the HDM2 and HDMX interaction

  2018cites this paper
• Structural and functional characterization of hMEX‐3C Ring finger domain as an E3 ubiquitin ligase

  2018influential citation
• The RING domain of RING Finger 11 (RNF11) protein binds Ubc13 and inhibits formation of polyubiquitin chains

  2018cites this paper
• Insights into the Tumor Suppressor p53 : Physiological Function and Proteolytic Regulation

  2017cites this paper
• Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity

  2017cites this paper
• p53 and RAD9, the DNA Damage Response, and Regulation of Transcription Networks

  2017influential citation
• Alterations of p 63 and p 73 in Human Cancers

  2017cites this paper
• Mouse modelling of the MDM2/MDMX−p53 signalling axis

  2017cites this paper
• Inhibition of MDM2 by a Rhein-Derived Compound AQ-101 Suppresses Cancer Development in SCID Mice

  2017cites this paper
• The fate of murine double minute X (MdmX) is dictated by distinct signaling pathways through murine double minute 2 (Mdm2)

  2017cites this paper
• The self-association and activity regulation of LRSAM1 E3 ligase.

  2017cites this paper
• Structural and functional basis for TRIM25 E3 ligase catalytic activity and NS1-mediated suppression

  2017cites this paper
• Live and let die: insights into pseudoenzyme mechanisms from structure.

  2017cites this paper
• Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen

  2017cites this paper
• Structure-activity studies of Mdm2/Mdm4-binding stapled peptides comprising non-natural amino acids

  2017cites this paper
• Monitoring p53 by MDM2 and MDMX is required for endocrine pancreas development and function in a spatio-temporal manner.

  2017cites this paper
• Highly Disordered Proteins in Prostate Cancer.

  2017cites this paper
• AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX–MDM2 complex

  2017cites this paper
• The activity of TRAF RING homo- and heterodimers is regulated by zinc finger 1

  2017cites this paper
• Anatomy of Mdm2 and Mdm4 in evolution

  2017cites this paper
• Mdm2 Splice isoforms regulate the p53/Mdm2/Mdm4 regulatory circuit via RING domain-mediated ubiquitination of p53 and Mdm4

  2017cites this paper
• Zinc-finger proteins in health and disease

  2017cites this paper